Research Article
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study
Table 3
Quality of life and nutrition condition for all patients.
| Variables | Combined group () | Control group () | |
| KPS score | | | | Before treatment | 81.4 ± 10.3 | 80.2 ± 12.0 | 0.674 | After treatment | 70.7 ± 13.4 | 80.1 ± 12.0 | 0.005 | Nutrition condition, (%) | | | | Before treatment | | | 0.580 | 0 | 0 (0) | 0 (0) | | 1 | 15 (48.4) | 14 (45.2) | | 2 | 9 (29.0) | 8 (25.8) | | ≥3 | 7 (22.6) | 9 (29.0) | | After treatment | | | 0.009 | 0 | 0 (0) | 0 (0) | | 1 | 4 (12.9) | 8 (25.8) | | 2 | 11 (35.5) | 13 (41.9) | | ≥3 | 16 (51.6) | 10 (32.2) | |
|
|